| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/29/1999 | WO1999037676A1 Recombinant human mannan-binding proteins and process for producing the same |
| 07/29/1999 | WO1999037652A1 Tricyclic indolene substituted oxazolidinones |
| 07/29/1999 | WO1999037641A1 Novel bicyclene-substituted oxazolidinones |
| 07/29/1999 | WO1999037635A1 Quinoline derivatives as antibacterials |
| 07/29/1999 | WO1999037630A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| 07/29/1999 | WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 07/29/1999 | WO1999037617A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037609A1 Novel naphthyl-substituted and anilide-substituted sulfonamides |
| 07/29/1999 | WO1999037608A1 Novel naphthyl substituted and heterocyclic substituted sulfonamides |
| 07/29/1999 | WO1999037328A1 Preventives/remedies for aids |
| 07/29/1999 | WO1999037327A1 A virus vaccine of enhanced immunogenicity against aujeszky's disease |
| 07/29/1999 | WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | WO1999037322A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | WO1999037307A1 Pharmaceutically active compounds and methods of use thereof |
| 07/29/1999 | WO1999037306A1 Pharmaceutically active compounds and methods of use thereof |
| 07/29/1999 | WO1999021580A9 Reagents and immunoassay for the detection and quantitative determination of mycothiol and precursors thereof |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | WO1999012951A9 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | DE19802436A1 New N-aryl sulfonamides as antiviral agents, particularly against cytomegalovirus, e.g. in patients with acquired immune deficiency syndrome |
| 07/29/1999 | DE19802239A1 New oxazolidinone derivatives useful as antimicrobial agents against Gram-positive and some Gram-negative bacteria, mycobacteria, etc. |
| 07/29/1999 | DE19802235A1 New oxazolidinone derivatives useful as antibacterial agents for treating local or systemic infections in humans or animals |
| 07/29/1999 | DE19753176A1 New non-recombinant sub-unit vaccine useful for protecting patients against bacterial infection |
| 07/29/1999 | CA2320624A1 Mutants of il-16, processes for their production, and their use |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2318969A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| 07/29/1999 | CA2318842A1 Quinoline derivatives as antibacterials |
| 07/29/1999 | CA2318580A1 Pharmaceutically active compounds and methods of use thereof |
| 07/29/1999 | CA2318382A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | CA2318182A1 Novel naphthyl-substituted and anilide-substituted sulfonamides |
| 07/29/1999 | CA2318100A1 Chemokine receptor antagonists and methods of use therefor |
| 07/28/1999 | EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 07/28/1999 | EP0931544A2 NF-kB activity inhibitor |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931093A1 Helicobacter pylori live vaccine |
| 07/28/1999 | EP0931091A1 Inhibitors of pla 2 |
| 07/28/1999 | EP0931088A1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs |
| 07/28/1999 | EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 07/28/1999 | EP0931084A1 1,3-dicarboxylic germanium complex and its therapeutic use |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931071A1 Methods of making hiv-protease inhibitors and intermediates for making them |
| 07/28/1999 | EP0931056A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| 07/28/1999 | EP0930894A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0930888A1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 07/28/1999 | EP0930886A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 07/28/1999 | EP0930885A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 07/28/1999 | EP0930821A1 Antimicrobial lipids |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | CN1223862A External use medicine for treating open wound |
| 07/28/1999 | CN1223859A Process for preparation of pharmaceutical composition |
| 07/28/1999 | CN1044366C Aryl-pyrrolidine-dione derivs., their preparing process and insecticidal and herbicidal agents contg. them and insecticidal and herbicidal use thereof |
| 07/28/1999 | CN1044320C Semduramicin premix preparing process |
| 07/27/1999 | US5929248 Antibacterial agents |
| 07/27/1999 | US5929226 Three or more but not all nucleotides are connected with methylphosphonothioate linkages where sulfur is not bridging atom; increased resistance to nucleases, increased duplex stability |
| 07/27/1999 | US5929220 Hepadnavirus receptor |
| 07/27/1999 | US5929123 Antioxidant compounds |
| 07/27/1999 | US5929117 Immunotherapeutic agents |
| 07/27/1999 | US5929114 Administering antiviral compound which extrudes zinc from nucleocapsid protein of human immunodeficiency virus |
| 07/27/1999 | US5929047 Anti-viral agent prepared by basic and acidic extraction of mangraves |
| 07/27/1999 | US5929045 Screening for bactericides |
| 07/27/1999 | US5929038 Administering iridoid compounds |
| 07/27/1999 | US5928930 Prevention and treatment of retroviral disease |
| 07/27/1999 | US5928928 For diagnosis of infections; for fungicides, antiprotozoa agents, antihelminthic agents; in body lotions, dentrifices, foods; for temporary implants; time-release agents |
| 07/27/1999 | US5928913 Herpes virus amplicon coding for antigen or immunomodulatory protein with replication-deficient helper herpes virus; for gene therapy and vaccines |
| 07/27/1999 | US5928900 Amino acid sequences from streptococcus pneumoniae |
| 07/27/1999 | US5928895 IgA Fc binding protein |
| 07/27/1999 | US5928865 Nucleic acids from region located 5' to cytotoxin associated protein locus; for diagnosis of gastrointestinal disorders associated with this bacteria; vaccines; antiulcer agents |
| 07/27/1999 | US5928861 Using specific antibodies against an epitope in the envelope protein gp46 for the detection of human t-cell leukemia virus in humans |
| 07/27/1999 | US5928651 Immunogenic properties |
| 07/27/1999 | US5928650 Preventing bacterial meningitis caused by serogroup b using anon-polysaccharide |
| 07/27/1999 | US5928648 Recombinant herpesvirus of turkeys and uses thereof |
| 07/27/1999 | US5928647 Immunization with non-replicating protein antigens. the compositions of the invention comprise a particulate-protein complex |
| 07/27/1999 | US5928642 Diagnosis and treatment of AIDS onset |
| 07/27/1999 | US5928640 Administering a protease to human or animal patient to inhibit increased intenstinal fluid seceretion induced by non-bacterial secretagogue |
| 07/27/1999 | US5928636 Injecting synergistic mixture to treat herpes, hepatitis, papilloma and human t-cell leukemia/lymphoma viruses; administering as bactericide, parasiticide, and/or antiprotozoa agent |
| 07/27/1999 | US5928624 Compositions for neutralization of lipopolysaccharides |
| 07/27/1999 | CA2170622C Oral formulations of an antifungal |
| 07/27/1999 | CA2158853C New anti viral compounds |
| 07/27/1999 | CA1340684C Antiherpes pentapeptides |
| 07/27/1999 | CA1340682C Antiviral peptides having a 2-oxoalkyl amino acid side chain |
| 07/22/1999 | WO1999036544A2 Neisseria meningitidis antigens |
| 07/22/1999 | WO1999036531A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells |
| 07/22/1999 | WO1999036518A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | WO1999036508A1 Histidine kinase |
| 07/22/1999 | WO1999036434A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus |
| 07/22/1999 | WO1999036426A1 N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE) |
| 07/22/1999 | WO1999036422A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme |
| 07/22/1999 | WO1999036415A1 Thioether furan nitrone compounds |
| 07/22/1999 | WO1999036410A1 Triazine antiviral compounds |
| 07/22/1999 | WO1999036406A1 Antivirals |
| 07/22/1999 | WO1999036404A1 Bisulfate salt of hiv protease inhibitor |
| 07/22/1999 | WO1999036384A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 07/22/1999 | WO1999036092A2 Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells |
| 07/22/1999 | WO1999036091A2 Method for inhibiting cd95-independent apoptosis in aids |
| 07/22/1999 | WO1999036087A1 Novel vaccine compositions for herpes simplex virus |
| 07/22/1999 | WO1999036086A1 Lipooligosaccharide-based vaccine for prevention of moraxella (branhamella) catarrhalis infections in mammals |
| 07/22/1999 | WO1999036084A1 Vaccine composition for herpes simplex virus and methods of using |